Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Meinian Onehealth Healthcare Holdings Co., Ltd.
  6. News
  7. Summary
    002044   CNE000001LV7

MEINIAN ONEHEALTH HEALTHCARE HOLDINGS CO., LTD.

(002044)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Beijing Future Health Technology Co., Ltd., Shanghai Peizhan Investment Management Center (Limited Partnership), Gong Yudong and Zhou Quan completed the acquisition of 7.5519% stake in Meiyin Health Technology Co., Ltd. from Meinian Onehealth Healthcare Holdings Co., Ltd..

03/19/2021 EDT

Beijing Future Health Technology Co., Ltd., Shanghai Peizhan Investment Management Center (Limited Partnership), Gong Yudong and Zhou Quan agreed to acquire 7.5519% stake in Meiyin Health Technology (Beijing) Co., Ltd. from Meinian Onehealth Healthcare Holdings Co., Ltd. (SZSE:002044) for approximately CNY 200 million on March 1, 2021. As per the agreement, Beijing Future Health Technology Co., Ltd., Shanghai Peizhan Investment Management Center (Limited Partnership), Gong Yudong and Zhou Quan will acquire 5%, 1.6667%, 0.7% and 0.2% stake in Meiyin Health Technology (Beijing) Co., Ltd. respectively. Post deal completion, Meinian Onehealth Healthcare Holdings Co., Ltd. will still hold 20.9999% stake in Meiyin Health Technology (Beijing) Co., Ltd. In June 30, 2020, Meiyin Health Technology (Beijing) Co., Ltd. reported a total asset of CNY 405 million and total common equity of CNY 333 million. The Board of Directors of Meinian Onehealth Healthcare Holdings Co., Ltd. approved the transaction. Beijing Future Health Technology Co., Ltd., Shanghai Peizhan Investment Management Center (Limited Partnership), Gong Yudong and Zhou Quan completed the acquisition of 7.5519% stake in Meiyin Health Technology (Beijing) Co., Ltd. from Meinian Onehealth Healthcare Holdings Co., Ltd. (SZSE:002044) on March 19, 2021.


© S&P Capital IQ 2021
All news about MEINIAN ONEHEALTH HEALTHCARE HOLDINGS CO., LTD.
09/10Meinian Onehealth Healthcare Holdings Co., Ltd. announced that it expects to ..
CI
08/30Meinian Onehealth Healthcare Holdings Co., Ltd. Reports Earnings Results for ..
CI
06/02China shares end lower on profit-booking of tech, healthcare stocks
RE
04/29Meinian Onehealth Healthcare Holdings Co., Ltd. Reports Earnings Results for ..
CI
04/12Meinian Onehealth Healthcare Holdings Co., Ltd. Reports Earnings Results for ..
CI
03/19Beijing Future Health Technology Co., Ltd., Shanghai Peizhan Investment Manag..
CI
03/18ANALYSIS : China's small tech firms step out of the shadows as giants reel from ..
RE
03/02Beijing Future Health Technology Co., Ltd., Shanghai Peizhan Investment Manag..
CI
03/01Meinian Onehealth Healthcare to Sell 7.6% Stake in Mega Genomics
CI
2020Chengdu Jinniu Meinian Health Management Consulting Co., Ltd. announced that ..
CI
More news
Financials
Sales 2021 8 852 M 1 369 M 1 369 M
Net income 2021 583 M 90,2 M 90,2 M
Net Debt 2021 - - -
P/E ratio 2021 54,4x
Yield 2021 -
Capitalization 31 746 M 4 910 M 4 910 M
Capi. / Sales 2021 3,59x
Capi. / Sales 2022 2,99x
Nbr of Employees -
Free-Float 63,4%
Chart MEINIAN ONEHEALTH HEALTHCARE HOLDINGS CO., LTD.
Duration : Period :
Meinian Onehealth Healthcare Holdings Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEINIAN ONEHEALTH HEALTHCARE HOLDINGS CO., LTD.
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Last Close Price 8,16 CNY
Average target price 8,50 CNY
Spread / Average Target 4,17%
EPS Revisions
Managers and Directors
Ke Xu President & Director
Rong Yu Chairman
Jun Ge Independent Non-Executive Director
Xiao Liu Independent Director
Yong Liu Independent Director